Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
01/1998
01/29/1998WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
01/29/1998WO1998003476A1 Anilinopeptide derivatives
01/29/1998WO1998003200A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease
01/29/1998WO1998003199A1 Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
01/29/1998WO1998003198A1 Polynucleotide vaccine formula for treating horse diseases
01/29/1998WO1998003197A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection
01/29/1998WO1998003196A1 Intradermal bovine polynucleotide vaccine
01/29/1998WO1998003192A1 Cyclic peptides having broad spectrum antimicrobial activity
01/29/1998WO1998003189A1 Use of conantokins
01/29/1998WO1997047270A3 Novel anti-viral compounds
01/29/1998CA2588670A1 Vectors for inhibiting hiv and tumor growth
01/29/1998CA2262863A1 Antiviral linear polymers
01/29/1998CA2262007A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection
01/29/1998CA2261797A1 Cyclic peptides having broad spectrum antimicrobial activity
01/29/1998CA2261570A1 Use of conantokins
01/29/1998CA2261343A1 Avian polynucleotide vaccine formula
01/29/1998CA2260799A1 Compounds, compositions and methods for treating influenza
01/28/1998EP0820998A2 Novel coumarin quinolone carboxylic acids and processes for the preparation thereof
01/28/1998EP0820472A1 Monoclonal antiidiotypic antibodies (ab2) and uses thereof
01/28/1998EP0820470A1 Novel anti-aids immunotoxins
01/28/1998EP0820469A1 Identification, purification and uses of leczymes and carbohydrate ligands
01/28/1998EP0820462A1 Cleavage of rna using metal complexes
01/28/1998EP0820461A1 Chemical compounds
01/28/1998EP0820455A1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
01/28/1998EP0820445A1 Inhibitors of farnesyl-protein transferase
01/28/1998EP0820282A1 A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals
01/28/1998EP0820281A1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
01/28/1998EP0559752B1 Optical isomers of 7- 3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents
01/28/1998CN1171814A Polynucleotide tuberculosis vaccine
01/28/1998CN1171790A Novel aminooligosaccharide derivative and process for preparing same
01/28/1998CN1171743A Novel tumor suppressor gene HIC-1
01/28/1998CN1037180C Process for preparing antimicrobial carbapenem derivatives
01/28/1998CN1037177C Process for preparation of substituted propargyl azacyclic butanone
01/27/1998US5712417 Inhibitors of retroviral proteases
01/27/1998US5712378 Sugar molecule is substituted with hydrocarbon or substituted hydrocarbon groups, antisense agents
01/27/1998US5712377 Glycosides isolated from pollen, their sugar-free decomposition products and derivatives thereof
01/27/1998US5712291 Methods and compositions for inhibition of angiogenesis
01/27/1998US5712129 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity
01/27/1998US5712118 Vaccine for branhamella catarrhalis
01/27/1998US5712104 Screening test for cancer, aids/hiv, influenza
01/27/1998US5712102 Method of screening compounds which inhibit P. gingivalis lipopolysaccharide from inhibiting the extravasation of leukocytes
01/27/1998US5711944 Interferon polymer conjugates
01/27/1998CA2016343C Preparation of diazabicyclic intermediates
01/27/1998CA1339646C Neplanocin derivatives
01/26/1998CA2210448A1 Novel coumarin quinolone carboxylic acids and processes for the preparation thereof
01/26/1998CA2182046A1 Haemophilus adhesin protein
01/22/1998WO1998002547A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications
01/22/1998WO1998002546A2 Dna immunization against chlamydia infection
01/22/1998WO1998002530A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
01/22/1998WO1998002463A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCα RECEPTOR ANTIBODIES
01/22/1998WO1998002457A1 Subunit respiratory syncytial virus vaccine preparation
01/22/1998WO1998002447A1 Bromotiacumicin compounds
01/22/1998WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
01/22/1998WO1998002177A1 Wound healing accelerators
01/22/1998WO1998002144A1 Compositions containing at least one nucleic acid
01/22/1998WO1998002038A1 Precise efficacy assay methods for active agents including chemotherapeutic agents
01/22/1998WO1996020698A3 Surface-modified nanoparticles and method of making and using same
01/22/1998CA2436126A1 Subunit respiratory syncytial virus vaccine preparation
01/22/1998CA2260284A1 Compositions containing at least one nucleic acid
01/22/1998CA2260258A1 Wound healing accelerators
01/22/1998CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
01/22/1998CA2260079A1 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications
01/22/1998CA2259371A1 Therapeutic multispecific compounds comprised of anti-fc.alpha. receptor antibodies
01/22/1998CA2257984A1 Bromotiacumicin compounds
01/22/1998CA2257823A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
01/21/1998EP0819681A2 N-(4-Aryl-thiazol-2-yl)-sulfonamides and their use
01/21/1998EP0819380A1 Bacteriocidal, antibacterial and bacteriostatic composition
01/21/1998EP0819124A1 Azole compounds with antimycotic activity for human and veterinary use
01/21/1998EP0819008A1 Method of using lectins for prevention and treatment of skin diseases and disorders
01/21/1998EP0701612B1 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS
01/21/1998EP0650363B1 Antiviral combinations
01/21/1998EP0528859B1 Oral vaccine comprising antigen surface-associated with red blood cells
01/21/1998CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases
01/21/1998CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases
01/21/1998CN1171112A Amino acid nucleic acids
01/21/1998CN1171111A Diclavulanate salt of diamino ether and its preparing method
01/21/1998CN1171110A Production of cefotaxime and new sodium salts
01/21/1998CN1171109A Novel quinuclidine derivatives and medicinal composition thereof
01/21/1998CN1171108A 8-alkoxyquinolonecarboxylic acid with excellent stability and process for producing the same
01/21/1998CN1170760A Improvements in sustainable cell line for production of Marek's Disease Vaccines
01/21/1998CN1170606A Compositions having inhibitive activity against 5 alpha-reductase and antibacterial activity against propionibacterium acnes
01/21/1998CN1170576A Basin bath medicinal liquid for curing tinea pedis, sweaty feet and smelly feet
01/21/1998CN1037063C Preparation method for antibacterial composition of oral administration
01/20/1998US5710171 Anticancer and antitumor agents
01/20/1998US5710156 Ester and carbamate derivatives of azolones
01/20/1998US5710154 Tetrahydrofuran antifungals
01/20/1998US5710147 7-benzyloxyimino-cephalosporins
01/20/1998US5710146 Antibiotics for bactericides
01/20/1998US5710140 Phenyl heterocycles as COX-2 inhibitors
01/20/1998US5710124 Method for combatting bovine mastitis
01/20/1998US5710035 Human elastase IV
01/20/1998US5709996 Self-assembling recombinant papillomavirus capsid proteins
01/20/1998US5709995 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
01/20/1998US5709860 Induction of cytotoxic T-lymphocyte responses
01/20/1998US5709851 Preparing a stable, aqueous iodine composition
01/20/1998CA2045212C Anti-virus agent
01/19/1998CA2210613A1 N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use
01/15/1998WO1998001571A2 Erythromycins and process for their preparation
01/15/1998WO1998001564A1 Hiv envelope polypeptides and vaccine
01/15/1998WO1998001558A2 Protein and peptide vaccines for inducing mucosal immunity